Fixed-dose combination
Gramicidin, Neomycin and Polymyxin b is a fixed-dose combination of an aminoglycoside antibacterial and a polymyxin-class antibacterial. It is available as eye drops for ophthalmic use. MedsAcross supplies Gramicidin, Neomycin and Polymyxin b for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Neomycin and polymyxin B sulfates and gramicidin ophthalmic solution is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis.
Source: US FDA prescribing information
Instill one or two drops into the affected eye every 4 hours for 7 to 10 days. In severe infections, dosage may be increased to as much as two drops every hour. donot
Source: US FDA prescribing information
This product is contraindicated in those persons who have shown hypersensitivity to any of its components.
Source: US FDA prescribing information
NOT FOR INJECTION INTO THE EYE. This product should never be directly introduced into the anterior chamber of the eye or injected subconjunctivally. Topical antibiotics, particularly neomycin sulfate, may cause cutaneous sensitization. A precise incidence of hypersensitivity reactions (primarily skin rash) due to topical antibiotics is not known. The manifestations of sensitization to topical antibiotics are usually itching, reddening and edema of the conjunctiva and eyelid. A sensitization reaction may manifest simply as a failure to heal. During long-term use of topical antibiotic products, periodic examination for such signs is advisable, and the patient should be told to discontinue the product if they are observed. Symptoms usually subside quickly on withdrawing the medication. Applications of products containing these ingredients should be avoided for the patient thereafter.
Source: US FDA prescribing information
Adverse reactions have occurred with the anti-infective components of this product. The exact incidence is not known. Reactions occurring most often are allergic reactions including itching, swelling, and conjunctival erythema. More serious hypersensitivity reactions, including anaphylaxis, have been reported rarely. Local irritation on instillation has also been reported.
Source: US FDA prescribing information
Store between 15°C to 25°C (59°F to 77°F). PROTECT FROM LIGHT.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
1 presentations of Gramicidin, Neomycin and Polymyxin b, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Neomycin And Polymyxin B Sulfates And Gramicidin 0.025 mg/1.75 mg/10000 units per mL eye dropsOphthalmic | Gramicidin, Neomycin and Polymyxin b | Bausch & Lomb | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 1 presentations of Gramicidin, Neomycin and Polymyxin b and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Gramicidin, Neomycin and Polymyxin b, including Neomycin And Polymyxin B Sulfates And Gramicidin.
No listed presentation of Gramicidin, Neomycin and Polymyxin b is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.